Are you Dr. Dandrea?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 56 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
44 Binney St
Dana Farber Cancer Institute
Boston, MA 02115Phone+1 617-632-2112Fax+1 617-632-5757- Is this information wrong?
Summary
- Dr. Alan Dandrea, MD is a pediatric hematologist/oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Pennsylvania. He is affiliated with Dana-Farber Cancer Institute.
Education & Training
Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1989 - 1990- Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1986 - 1989
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1983 - 1986
Harvard Medical SchoolClass of 1983
Certifications & Licensure
MA State Medical License 1987 - 2025
PA State Medical License 1985 - 1986- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 14 citationsThe Protexin complex counters resection on stalled forks to promote homologous recombination and crosslink repair.Richard O. Adeyemi, Nicholas A. Willis, Andrew E. H. Elia, Connor Clairmont, Shibo Li, Xiaohua Wu, Alan D. D'Andrea, Ralph Scully, Stephen J. Elledge> ;Molecular Cell. 2021 Nov 4
- 1 citationsIsolation of human and murine hematopoietic stem cells for DNA damage and DNA repair assays.Alfredo E. Rodriguez, Jessica Filiatrault, Patricia Flores-Guzmán, Hector Mayani, Kalindi Parmar, Alan D. D'Andrea> ;STAR Protocols. 2021 Sep 27
- 27 citationsA Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancerPanagiotis A. Konstantinopoulos, Alexandre André B.A. da Costa, Doga Gulhan, Elizabeth K. Lee, Su Chun Cheng, Andrea E. Wahner Hendrickson, Bose Kochupurakkal, David L...> ;Nature Communications. 2021 Sep 22
- Join now to see all
Press Mentions
Dana-Farber Clinical Investigators Leverage Rich Patient Samples to Pursue Novel Cancer TherapiesDecember 3rd, 2019
Clinical Trial Underscores Promise of Immunotherapy, in Combination with Second Drug, for Ovarian CancerJuly 13th, 2019
PARI (PARPBP) Suppresses Replication Stress-Induced Myeloid Differentiation in Leukemia CellsJuly 1st, 2019- Join now to see all
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
